-
APASL 2023 | Prof. Ning Qin: New Strategies for Targeting Liver Autophagy Abnormalities in Fatty Liver Disease Interventions
Editor’s Note: In recent years, the global incidence of Non-Alcoholic Fatty Liver Disease (NAFLD) has been continuously rising, becoming the most common cause of chronic liver disease worldwide, with an…
-
APASL 2023 | Prof. Wu Chao: Metabolic Predictors and Liver Fibrosis Diagnostic Model Construction for Chronic Hepatitis B Combined with NAFLD
Editor’s Note: Chronic hepatitis B (CHB) is the primary cause of chronic liver disease in China and other Asian countries, as well as a major contributor to liver-related morbidity and…
-
APASL 2023 | Prof. Hou Jinlin: The New Hepatitis B Drug ALG-000184 Combined with Entecavir Shows Stronger Antiviral Activity Than Entecavir Alone
Editor’s Note: Chronic hepatitis B virus (HBV) infection is a global epidemic, yet we still lack a treatment that can completely conquer HBV. At present, most patients still need long-term…
-
Dr. Lai Wei talk about the Renaming of NAFLD to MASLD, Exploration of the Hepatitis B Research Paradigm, and Highlights from the 2023 EASL Congress
Dr. Lai Wei talk about the Renaming of NAFLD to MASLD, Exploration of the Hepatitis B Research Paradigm, and Highlights from the 2023 EASL Congress Dr. Lai Wei is a Professor of Hepatology & Medicine, and is the Director of the Hepatobiliary and Pancreatic Center at Beijing Tsinghua Changgung Hospital. His current research interests involve…
-
Dr. Youwen Tan: Baseline Hepatocyte Ballooning is a Risk Factor for the Evolution of Non-Alcoholic Fatty Liver Disease in Chronic Hepatitis B
Chronic hepatitis B (CHB) and non-alcoholic fatty liver disease (NAFLD) are both significant contributors to liver-related complications and mortality. Dr. Youwen Tan’s team at the Third People’s Hospital of Jiangsu University conducted research on the impact of NAFLD, as confirmed by liver histopathology, and pathological changes on individuals with chronic HBV infection. The latest research…
-
President Doctor Shuichiro Shiina Invites You to Attend the 2024 the Asian Pacific Association for the Study of the Liver Conference in Kyoto, Japan
At the 58th European Association for the Study of the Liver (EASL) Annual Meeting, also known as EASL 2023 Congress, Professor Shuichiro Shiina, the President of the Asian Pacific Association…
-
Dr. Yanhua Ding’s Team: Clinical Research on HBV CAM New Drugs and NAFLD Prediction Model Selected for Conference Presentation
Dr. Yanhua Ding’s Team: Clinical Research on HBV CAM New Drugs and NAFLD Prediction Model Selected for Conference Presentation Yanhua Ding practices in Changchun, China. Ding and is rated as an Experienced expert by MediFind in the treatment of Arthritis. They are also highly rated in 3 other conditions, according to our data. Their top…
-
Doctor Tarik Asselah: Beyond Liver Cancer, Viral Hepatitis Is Also Linked to Some Extrahepatic Malignancies
Doctor Tarik Asselah: Beyond Liver Cancer, Viral Hepatitis Is Also Linked to Some Extrahepatic Malignancies Tarik Asselah is a Full Professor of Medicine and Hepatology at Hôpital Beaujon, APHP, Clichy, France, and at the University of Paris, France. Tarik Asselah is the Head of Viral Hepatitis at INSERM (UMR 1149, Centre de Recherche sur l’Inflammation).…
Connecting Medical Expertise through Media